SALT LAKE CITY, UT -- (MARKET WIRE) -- November 08, 2006 -- BSD Medical Corp. (AMEX: BSM) today announced that breakthrough uses of hyperthermia therapy in treating both recurrent and primary breast cancer drew much attention and was a major highlight at the twelfth annual Puerto Rico Breast Cancer Conference held in conjunction with the American Cancer Society October 27-29 in San Juan. BSD Medical was a sponsor of the conference, along with co-sponsors including Bristol Myers Squibb, Pfizer, Johnson & Johnson, Merck and Abbott. The congress faculty represented opinion leaders from major universities and cancer research organizations.
